UNIONDALE, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and consumer products company, today announced that ...
ProPhase Labs (PRPH) explores sale/partnership for BE-Smart esophageal cancer test and updates Crown Medical COVID claim recoveries.
ProPhase Labs is embarking on a significant financial restructuring, pivoting its strategy to bolster its balance sheet. The company has formally initiated the sale process for its esophageal cancer ...
Each Initiative Has the Potential to Drive Significant Liquidity and Strengthen the Company’s Balance SheetUNIONDALE, NY, Feb. 03, 2026 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results